日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Unveiling phytoconstituents and the anti-inflammatory potential of Crassula tetragona L. in ulcerative colitis: A focus on the PPARγ/SIRT1 axis

揭示景天属植物(Crassula tetragona L.)的植物成分及其在溃疡性结肠炎中的抗炎潜力:聚焦于PPARγ/SIRT1轴

Raslan, Mona A; Abdel-Rahman, Rehab F; Fayed, Hany M; Elbaset, Marawan A; Taher, Rehab F

Apigenin attenuates obesity-associated hepatic dysfunction and fibrosis in rats: an integrated biochemical, histological, and ex vivo dielectric study

芹菜素可减轻大鼠肥胖相关的肝功能障碍和纤维化:一项综合生物化学、组织学和离体介电性能的研究

Moussa, Sherif Abdelmottaleb; Aziz, Samir; Abdel-Rahman, Rehab F; Elbaset, Marawan A; Fayed, Hany M; Shabana, Marwa E; Ibrahim, Fatma A; Bashandy, Samir A E

Protective role of remogliflozin against experimental liver fibrosis by activating AMPK/SIRT1/Nrf2 and suppressing NF-κB pathways.

雷莫格列净通过激活 AMPK/SIRT1/Nrf2 和抑制 NF-κB 通路发挥对实验性肝纤维化的保护作用

ALSuhaymi Naif, Alsugoor Mahdi H, Shokry Aya A, Fayed Hany M, Mohamed Bassim M S A, Afifi Sherif M, Esatbeyoglu Tuba, Korany Reda M S, Elbaset Marawan A

Therapeutic potential of canagliflozin in DEN/TAA-induced renal cancer: mechanistic insights into NLRP3/IL-6/STAT3 and AMPK signaling and oxidative stress regulation.

卡格列净在 DEN/TAA 诱导的肾癌中的治疗潜力:对 NLRP3/IL-6/STAT3 和 AMPK 信号传导和氧化应激调节的机制见解。

Abdel-Rahman Rehab F, Alsugoor Mahdi H, ALSuhaymi Naif, Fayed Hany M, Mahmoud Sawsan S, Ibrahim Fatma A, Elbaset Marawan A

Therapeutic efficacy of canagliflozin against hepatocarcinogenesis induced by CDD/DEN/TAA in a rat model: regulation of AMPK/HIF-1α/YAP-1/TAZ signaling pathways

卡格列净对 CDD/DEN/TAA 诱导的大鼠肝癌发生的治疗效果:AMPK/HIF-1α/YAP-1/TAZ 信号通路的调控

Fayed, Hany M; Asaad, Gihan F; Elbaset, Marawan A; Sharaf, Ola A; Mahmoud, Sawsan S; Amin, Mohamed M; El-Gendy, Zeinab A; Ibrahim, Fatma A; Abdelgayed, Sherein S; Abdel-Rahman, Rehab F

Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats.

索格列净通过调节 SIRT1/Nrf2 和 PI3K/AKT 信号通路改善大鼠实验性肝纤维化。

Elbadawy Hossein M, Almikhlafi Mohannad A, Alsubhi Mohammed H, Shokry Aya A, Fayed Hany M, Mohamed Bassim M S A, Afifi Sherif M, Esatbeyoglu Tuba, Korany Reda M S, Elbaset Marawan A

Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches

目前肝纤维化治疗的研究方向:FDA批准药物的再利用与其他新兴疗法

Mohammed, Omima S; Attia, Hany G; Mohamed, Bassim M S A; Elbaset, Marawan A; Fayed, Hany M